Eurofins-Cerep SA (EPA:ALECR)
18,400
0.00 (0.00%)
At close: Nov 11, 2026
Eurofins-Cerep Market Cap
Eurofins-Cerep has a market cap or net worth of €92.81 million as of November 11, 2026. It is the 24,755th most valuable company in the world and the 300th biggest in France. Its market cap has increased by 14.29% in one year.
Market Cap
92.81M
Enterprise Value
71.77M
Revenue
41.10M
Global Rank
Country Rank
#300 France
PE Ratio
19.41
ChartMarket Cap Chart
Since January 5, 2015, Eurofins-Cerep's market cap has decreased from 1.18B to 92.81M, a decrease of -92.12%. That is a compound annual growth rate of -19.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 92.81M | 3.37% |
| Dec 31, 2025 | 89.78M | -9.18% |
| Dec 31, 2024 | 98.86M | -21.60% |
| Dec 29, 2023 | 126.10M | 45.35% |
| Dec 23, 2021 | 86.76M | 32.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 102.97B |
| EssilorLuxottica Société anonyme | 86.22B |
| Sartorius Stedim Biotech | 21.74B |
| Eurofins Scientific SE | 14.99B |
| Innate Pharma | 123.68M |
| Sensorion | 83.06M |
| Guerbet | 82.80M |
| Cellectis | 76.26M |